• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
BCG vaccine in superficial bladder cancer.
BMJ. 1994 Mar 26;308(6932):801-2. doi: 10.1136/bmj.308.6932.801.
2
BCG immunotherapy of bladder cancer: 20 years on.膀胱癌的卡介苗免疫疗法：二十年回顾。
Lancet. 1999 May 15;353(9165):1689-94. doi: 10.1016/S0140-6736(98)07422-4.
3
[Results of BCG immunotherapy in the management of bladder tumors].[卡介苗免疫疗法在膀胱肿瘤治疗中的结果]
Orv Hetil. 1990 Aug 5;131(31):1697-702.
4
Nearly fatal complications of cervical lymphadenitis following BCG immunotherapy for superficial bladder cancer.
Respiration. 2001;68(4):420-1. doi: 10.1159/000050539.
5
Advances in the treatment of superficial bladder cancer: optimizing BCG immunotherapy. Introduction.
Eur Urol. 1995;27 Suppl 1:1.
6
Aspects of non-specific immunotherapy with BCG in superficial bladder cancer: an overview.
Prog Clin Biol Res. 1989;310:11-33.
7
The experience with intravesical BCG-immunotherapy in the management of superficial bladder cancer in the United Kingdom.英国膀胱内卡介苗免疫疗法治疗浅表性膀胱癌的经验。
Prog Clin Biol Res. 1989;310:147-51.
8
BCG-RIVM: a new BCG preparation for intravesical immunotherapy of superficial bladder cancer.BCG-RIVM：一种用于浅表性膀胱癌膀胱内免疫治疗的新型卡介苗制剂。
Chemioterapia. 1987 Jun;6(2 Suppl):713-6.
9
Re: Immunotherapy of superficial bladder cancer.
J Urol. 1983 Aug;130(2):368-9. doi: 10.1016/s0022-5347(17)51159-3.
10
BCG immunotherapy in superficial cancer of the bladder.
S Afr J Surg. 1985 Jun;23(2):53-4.

引用本文的文献

1
Use of licensed vaccines for active immunization of the immunocompromised host.使用经许可的疫苗对免疫功能低下宿主进行主动免疫。
Clin Microbiol Rev. 1998 Jan;11(1):1-26. doi: 10.1128/CMR.11.1.1.
2
Arthritis as a complication of intravesical BCG vaccine.关节炎作为膀胱内卡介苗疫苗的一种并发症。
BMJ. 1994 Jun 18;308(6944):1638. doi: 10.1136/bmj.308.6944.1638.

本文引用的文献

1
Superficial bladder cancer: progression and recurrence.浅表性膀胱癌：进展与复发
J Urol. 1983 Dec;130(6):1083-6. doi: 10.1016/s0022-5347(17)51695-x.
2
The plight of the patient with carcinoma in situ of the bladder.
J Urol. 1970 Feb;103(2):160-4. doi: 10.1016/s0022-5347(17)61913-x.
3
Risks and benefits of repeated courses of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer.卡介苗膀胱灌注重复疗程治疗浅表性膀胱癌的风险与获益
J Urol. 1987 Feb;137(2):220-4. doi: 10.1016/s0022-5347(17)43959-0.
4
Requirement of a thymus dependent immune response for BCG-mediated antitumor activity.卡介苗介导的抗肿瘤活性对胸腺依赖性免疫反应的需求。
J Urol. 1987 Jan;137(1):155-8. doi: 10.1016/s0022-5347(17)43909-7.
5
Bacillus Calmette-Guérin therapy alters the progression of superficial bladder cancer.
J Clin Oncol. 1988 Sep;6(9):1450-5. doi: 10.1200/JCO.1988.6.9.1450.
6
Bacillus Calmette-Guerin for treatment of superficial transitional cell carcinoma of the bladder in patients who have failed thiotepa and/or mitomycin C.
J Urol. 1987 May;137(5):871-3. doi: 10.1016/s0022-5347(17)44277-7.
7
The pT1 G3 bladder tumour.pT1 G3期膀胱肿瘤。
Br J Urol. 1989 Aug;64(2):109-16. doi: 10.1111/j.1464-410x.1989.tb05967.x.
8
BCG treatment of superficial transitional cell carcinoma.
Urology. 1991;37(5 Suppl):16-8. doi: 10.1016/0090-4295(91)80130-y.
9
Complications of bacillus Calmette-Guérin immunotherapy.卡介苗免疫疗法的并发症。
Urol Clin North Am. 1992 Aug;19(3):565-72.
10
Carcinoma in situ.原位癌
Urol Clin North Am. 1992 Aug;19(3):499-508.

BCG vaccine in superficial bladder cancer.

作者信息

Sharma N, Prescott S

出版信息

BMJ. 1994 Mar 26;308(6932):801-2. doi: 10.1136/bmj.308.6932.801.

DOI:10.1136/bmj.308.6932.801
PMID:8167481
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2539986/
Abstract
摘要